These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34838041)

  • 21. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.
    Antonadou D; Pepelassi M; Synodinou M; Puglisi M; Throuvalas N
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):739-47. PubMed ID: 11849797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
    Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva.
    Jellema AP; Slotman BJ; Doornaert P; Leemans CR; Langendijk JA
    Radiother Oncol; 2007 Oct; 85(1):83-9. PubMed ID: 17391790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MUC5B levels in submandibular gland saliva of patients treated with radiotherapy for head-and-neck cancer: a pilot study.
    Dijkema T; Terhaard CH; Roesink JM; Raaijmakers CP; van den Keijbus PA; Brand HS; Veerman EC
    Radiat Oncol; 2012 Jun; 7():91. PubMed ID: 22704532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT image biomarkers to improve patient-specific prediction of radiation-induced xerostomia and sticky saliva.
    van Dijk LV; Brouwer CL; van der Schaaf A; Burgerhof JGM; Beukinga RJ; Langendijk JA; Sijtsema NM; Steenbakkers RJHM
    Radiother Oncol; 2017 Feb; 122(2):185-191. PubMed ID: 27459902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.
    Jandu HK; Veal CD; Fachal L; Luccarini C; Aguado-Barrera ME; Altabas M; Azria D; Baten A; Bourgier C; Bultijnck R; Colciago RR; Farcy-Jacquet MP; Chang-Claude J; Choudhury A; Dunning A; Elliott RM; Green S; Gutiérrez-Enríquez S; Herskind C; Lambrecht M; Monten C; Rancati T; Reyes V; Rosenstein BS; De Ruysscher D; Carmen De Santis M; Seibold P; Sperk E; Veldwijk M; Paul Symonds R; Stobart H; Taboada-Valladares B; Vega A; Veldeman L; Webb AJ; Weltens C; West CM; Rattay T; Talbot CJ;
    Radiother Oncol; 2023 Oct; 187():109806. PubMed ID: 37437607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
    Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study.
    Lee E; Takita C; Wright JL; Slifer SH; Martin ER; Urbanic JJ; Langefeld CD; Lesser GJ; Shaw EG; Hu JJ
    Hum Genomics; 2019 Jun; 13(1):28. PubMed ID: 31196165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
    Kerns SL; Stock R; Stone N; Buckstein M; Shao Y; Campbell C; Rath L; De Ruysscher D; Lammering G; Hixson R; Cesaretti J; Terk M; Ostrer H; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e21-8. PubMed ID: 23021708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Prospective Cohort Study Analyzing Radiation-Induced Xerostomia and Quality of Life of Head and Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy and 3D Conformal Radiotherapy Techniques at a Tertiary Cancer Center in Eastern India.
    Sahoo B; Padhi S; Patra AC; Mahapatra BR; Mishra T; Mishra SR; Patro KC
    Cureus; 2023 Mar; 15(3):e36442. PubMed ID: 37090370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of very late xerostomia in head and neck cancer patients after irradiation.
    Blitzer GC; Rogus-Pulia NM; Paz C; Nickel KP; Cannaday VL; Kelm-Nelson CA; Sudakaran S; Chappell RJ; Glazer T; Kimple RJ
    Laryngoscope Investig Otolaryngol; 2022 Aug; 7(4):1018-1024. PubMed ID: 36000048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy.
    Kaae JK; Johnsen L; Hansen CR; Kristensen MH; Brink C; Eriksen JG
    Acta Oncol; 2019 Oct; 58(10):1366-1372. PubMed ID: 31241381
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic variants associated with mandibular osteoradionecrosis following radiotherapy for head and neck malignancy.
    Brooker RC; Antczak P; Liloglou T; Risk JM; Sacco JJ; Schache AG; Shaw RJ
    Radiother Oncol; 2021 Dec; 165():87-93. PubMed ID: 34757119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
    Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
    Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of an integrated supportive program on xerostomia and saliva characteristics in patients with head and neck cancer radiated with a low dose to the major salivary glands: a randomized controlled trial.
    Jiang N; Zhao Y; Stensson M; Mårtensson J
    BMC Oral Health; 2022 May; 22(1):199. PubMed ID: 35606811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures.
    Richards TM; Hurley T; Grove L; Harrington KJ; Carpenter GH; Proctor GB; Nutting CM
    Oral Dis; 2017 Oct; 23(7):990-1000. PubMed ID: 28434191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy.
    Baudelet M; Van den Steen L; Tomassen P; Bonte K; Deron P; Huvenne W; Rottey S; De Neve W; Sundahl N; Van Nuffelen G; Duprez F
    Head Neck; 2019 Oct; 41(10):3594-3603. PubMed ID: 31329343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene alterations as predictors of radiation-induced toxicity in head and neck squamous cell carcinoma.
    Sumner W; Ray X; Sutton L; Rebibo D; Marincola F; Sanghvi P; Moiseenko V; Deichaite I
    J Transl Med; 2021 May; 19(1):212. PubMed ID: 34001187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.
    Eisbruch A; Ship JA; Martel MK; Ten Haken RK; Marsh LH; Wolf GT; Esclamado RM; Bradford CR; Terrell JE; Gebarski SS; Lichter AS
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):469-80. PubMed ID: 8892473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.